Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06052241
Other study ID # B-2107-697-301
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 27, 2021
Est. completion date February 7, 2022

Study information

Verified date October 2023
Source Seoul National University Bundang Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators aimed to evaluate whether they can be improved by an AI-based personalized prescription of scalp cosmetics.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date February 7, 2022
Est. primary completion date January 7, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 19 Years and older
Eligibility Inclusion Criteria: 1. healthy adults aged >19 years 2. presence of scalp-related discomfort (such as itching, a sensation of heat, dandruff, excessive sebum, dryness, pain, or pimple) Exclusion Criteria: 1. presence of active infectious scalp diseases 2. history of treatment with topical or systemic steroids, oral immunosuppressants, topical or systemic antibiotics, or antifungal agents that could affect the scalp conditions, within 4 weeks prior to the baseline 3. difficulty understanding or following the protocol

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
shampoos and scalp serums
shampoos and scalp serums personalized according to their SPI-AI-defined scalp types

Locations

Country Name City State
Korea, Republic of Seoul National University Bundang Hospital Seongnam

Sponsors (1)

Lead Sponsor Collaborator
Seoul National University Bundang Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Total Scalp Photographic Index (SPI) score Change from the baseline in the total SPI score. The total SPI score (0-75 points) is the sum of the SPI score of five areas: vertex, anterior, posterior, right, and left. Higher SPI scores mean a worse condition, and larger changes from baseline in the total SPI score mean a better outcome. week 4
Secondary Total Scalp Photographic Index (SPI) score Change from the baseline in the total SPI score. The total SPI score (0-75 points) is the sum of the SPI score of five areas: vertex, anterior, posterior, right, and left. Higher SPI scores mean a worse condition, and larger changes from baseline in the total SPI score mean a better outcome. week 8
Secondary Total Scalp Photographic Index (SPI) score Change from the baseline in the total SPI score. The total SPI score (0-75 points) is the sum of the SPI score of five areas: vertex, anterior, posterior, right, and left. Higher SPI scores mean a worse condition, and larger changes from baseline in the total SPI score mean a better outcome. week 12
Secondary subjective improvement in scalp conditions proportion of participants achieving improvement in more than one item on the questionnaire week 4
Secondary participant's satisfaction proportion of participants satisfied with the products week 4
See also
  Status Clinical Trial Phase
Completed NCT00746109 - Study of Wound Packing After Superficial Skin Abscess Drainage Phase 4
Completed NCT00352612 - Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections Phase 4
Completed NCT05345093 - Evaluation of Safety and Performance of Ialuxid Gel in Treatment of Acne Vulgaris, and Folliculitis N/A
Completed NCT01094444 - Investigation of the Effect of Vitamin K3-lotion for the Treatment of Cetuximab Induced Folliculitis Phase 2
Completed NCT00289588 - An Attempt to Reduce Community-Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection in Soldiers N/A
Completed NCT05793164 - Characterization and Risk Factors of Folliculitis After Hair Transplantation
Completed NCT01126268 - Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection Phase 4
Suspended NCT01244256 - Efficacy and Comparative of the Association Beclomethasone Clotrimzaol + Gentamicin in Patients With Acne Contaminated Phase 2/Phase 3